Trade

with

Rosetta Genomics Ltd
(NASDAQ: ROSG)
AdChoices
2.98
-0.02
-0.66%
After Hours :
3.01
+0.03
+1.00%

Open

3.01

Previous Close

3.00

Volume (Avg)

34.88k (77.59k)

Day's Range

2.95-3.11

52Wk Range

2.35-6.69

Market Cap.

33.47M

Dividend Rate ( Yield )

-

Beta

-2.85

Shares Outstanding

11.23M

P/E Ratio (EPS)

-

AdChoices
Fundamentals
  • Key statistics
  • Growth
  • Profitability
  • Financial health
  • Price ratios
  • Trading statistics
  • Management effectiveness
Industry Diagnostics & Research
Highlights
Analyst Recommendation: Outperform
    • Revenue

    • 405.00k

    • Net Income

    • -12.90M

    • Market Cap.

    • 33.47M

    • Enterprise Value

    • -

    • Net Profit Margin %

    • -1,800.00

    • PEG (Price/Earnings Growth) Ratio

    • -

    • Beta

    • -2.85

    • Forward P/E

    • -3.97

    • Price/Sales

    • 40.49

    • Price/Book Value

    • 1.68

    • Price/Cash flow

    • -2.21

      • EBITDA

      • -12.85M

      • Return on Capital %

      • -53.07

      • Return on Equity %

      • -57.67

      • Return on Assets %

      • -53.07

      • Book Value/Share

      • 1.77

      • Shares Outstanding

      • 11.23M

      • Last Split Factor (Date)

      • -

      • Last Dividend (Ex-Date)

      • -

      • Dividend Declaration Date

      • -

      Analyst Recommendation
      10/17/2014
      Outperform
        • 1 Year Price Target

        • 7.75

        • Credit Rating

        • -

        • Analysts

        • 2

        • EPS Estimate

        • -1.00

        • Cashflow Estimate

        • -

        Morningstar Consensus estimate data
        • Growth Rate (%)

        • Company

        • Industry

          • Sales (Revenue)

            Q/Q (last year)

          • -68.60

          • 21.91

          • Net Income

            YTD/YTD (last year)

          • -

          • -5.55

          • Net Income

            Q/Q (last year)

          • -

          • 0.44

          • Sales (Revenue)

            5-Year Annual Average

          • -23.15

          • 47.82

          • Net Income

            5-Year Annual Average

          • -

          • 4.98

          • Dividends

            5-Year Annual Average

          • -

          • 5.31

          • Profit Margins (%)

          • Company

          • Industry

            • Gross Margin

            • -36.42

            • 42.70

            • Pre-Tax Margin

            • -1,800.00

            • 11.63

            • Net Profit Margin

            • -1,800.00

            • 9.55

            • Average Gross Margin

              5-Year Annual Average

            • -113.80

            • 43.76

            • Average Pre-Tax Margin

              5-Year Annual Average

            • -

            • 11.34

            • Average Net Profit Margin

              5-Year Annual Average

            • -6,650.30

            • 52.13B

            • Financial Ratios

            • Company

            • Industry

              • Debt/Equity Ratio

              • -

              • 0.62

              • Current Ratio

              • 13.82

              • 1.23

              • Quick Ratio

              • 13.79

              • 0.76

              • Interest Coverage

              • -598.48

              • 5.98

              • Leverage Ratio

              • 1.09

              • 2.16

              • Book Value/Share

              • 1.77

              • 14.94

              • Price Ratios

              • Company

              • Industry

                • Current P/E Ratio

                • -2.18

                • 32.15

                • P/E Ratio 5-Year High

                • -157.35

                • 325.07

                • P/E Ratio 5-Year Low

                • -1.06

                • 154.73

                • Price/Sales Ratio

                • 39.22

                • 2.24

                • Price/Book Value

                • 1.63

                • 2.92

                • Price/Cash Flow Ratio

                • -2.21

                • 18.35

                • Key Metrics

                • Company

                  • Shares Short

                    as of -

                  • -

                  • Short Ratio

                    as of -

                  • -

                  • Short % of Float

                    as of -

                  • -

                  • Shares Short

                    prior month

                  • -

                  • Trailing Annual Dividend Yield

                  • -

                  • 5 Year Average Dividend Yield

                  • -

                  • Key Metrics

                  • Company

                    • Payout Ratio

                    • -

                    • Dividend Date

                    • -

                    • Ex-Dividend Date

                    • -

                    • Last Split Factor

                      new per old

                    • -

                    • Last Split Date

                    • -

                    • Key Metrics

                    • Company

                    • Industry

                      • Return on Equity %

                        (5-Year Average)

                      • -57.67

                        (-)

                      • 9.34

                        (9.80)

                      • Return on Assets %

                        (5-Year Average)

                      • -53.07

                        (-121.90)

                      • 4.63

                        (5.44)

                      • Return on Capital %

                        (5-Year Average)

                      • -57.58

                        (-)

                      • 5.73

                        (6.77)

                      • Income/Employee

                      • -

                      • 17.17k

                      • Inventory Turnover

                      • -

                      • 5.07

                      • Asset Turnover

                      • 0.03

                      • 0.48

                      Current Historical
                      Financials
                      • Income Statement
                      • Balance Sheet
                      • Cash Flow
                      Operating Income
                      -13.35M
                      Operating Margin
                      -3,295.56
                      Total Equity
                      -
                      Retained Earnings
                      -
                      Free Cashflow
                      -
                      Price/Cashflow
                      -2.21
                      Ownership

                      Institutional Ownership

                      8.98%

                      Top 10 Institutions

                      8.72%

                      Mutual Fund Ownership

                      0.23%

                      Float

                      99.97%

                      5% / Insider Ownership

                      -

                      Corporate insiders or major stockholders reporting trading activity in the stock.

                      Top Mutual Fund Owners

                      Top Institutional Owners

                      Mutual Fund Name

                      Institution Name

                      • Mutual Fund Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • Philadelphia Invmt Ptnrs New Generation

                      •  

                        25,000

                      • 0.00

                      • 0.22

                      • Marketocracy Masters 100 Fund

                      •  

                        1,000

                      • 0.00

                      • 0.01

                      • Institution Name

                      • Shares Held

                      • % Change

                      • % Outstanding

                      • National Asset Management, Inc.

                      •  

                        512,830

                      • +38.95%

                      • 4.57

                      • Wells Fargo Advisors, LLC

                      •  

                        154,122

                      • +2,426.59%

                      • 1.37

                      • Highlander Capital Management LLC

                      •  

                        104,019

                      • -4.59%

                      • 0.93

                      • Susquehanna Financial Group, LLLP

                      •  

                        56,887

                      • +149.24%

                      • 0.51

                      • GRT Capital Partners LLC

                      •  

                        43,000

                      • -9.47%

                      • 0.38

                      • Philadelphia Investment Partners, LLC

                      •  

                        25,000

                      • 0.00%

                      • 0.22

                      • Spark Investment Management LLC

                      •  

                        11,300

                      • -78.27%

                      • 0.10

                      • Nomura Holdings Inc

                      •  

                        10,603

                      • -53.09%

                      • 0.10

                      • Knight Capital Americas LLC

                      •  

                        10,235

                      • -52.30%

                      • 0.09

                      Company Profile

                      Sector

                      Healthcare

                      Industry

                      Diagnostics & Research

                      Type

                      -

                      Style

                      Small Growth

                      Rosetta Genomics Ltd is engaged in the development and commercialization of new diagnostic tests and therapeutics based on a group of genes known as microRNAs.

                      Key People

                      Mr. Kenneth A. Berlin

                      CEO/President

                      Mr. Brian A. Markison

                      Chairman of the Board/Director

                      Ron Kalfus

                      CFO

                      Dr. Eti Meiri

                      Vice President, Divisional

                      David Sidransky,M.D.

                      Director

                      • Rosetta Genomics Ltd

                      • 10 Plaut Street

                      • Rehovot, 76706

                      • ISR.Map

                      • Phone: +972 732220700

                      • Fax: +972 732220701

                      • rosettagenomics.com

                      Incorporated

                      2000

                      Employees

                      45

                      Send Feedback

                      We appreciate your input!

                      • I'm having trouble signing into my Microsoft account

                      • I’m having problems with the services stripe (Mail, Facebook, etc.)

                      • There is an issue with my weather information

                      • I see an error in the content

                      • Other

                      Please give an overall site rating: